Total planned funding: $785,139,031
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $154,722,196 |
Kenya | $146,455,050 |
Zambia | $102,981,417 |
Uganda | $81,888,163 |
Tanzania | $74,912,088 |
Mozambique | $33,277,336 |
Rwanda | $30,628,169 |
Zimbabwe | $29,900,073 |
South Africa | $28,874,021 |
Côte d'Ivoire | $25,833,847 |
Vietnam | $21,598,765 |
Haiti | $18,192,154 |
Democratic Republic of the Congo | $13,686,038 |
Eswatini | $6,292,172 |
Botswana | $6,089,948 |
Ethiopia | $3,806,926 |
Ukraine | $2,605,290 |
Guyana | $2,121,954 |
Namibia | $939,798 |
Dominican Republic | $100,000 |
South Sudan | $80,453 |
Burundi | $54,720 |
Papua New Guinea | $35,833 |
Central Asia Region | $33,169 |
Cameroon | $27,160 |
Caribbean Region | $2,291 |
Organizational Types
Private Contractor | $587,990,553 |
NGO | $68,517,029 |
Host Country Government Agency | $66,880,470 |
Unknown | $26,549,986 |
Implementing Agency | $25,669,253 |
FBO | $3,382,295 |
University | $3,217,286 |
Own Agency | $1,858,533 |
Parastatal | $1,073,626 |
Program Areas
Treatment | $785,139,031 |
Budget Codes
HTXD: Treatment: ARV Drugs | $785,139,031 |
Top Partner Programs
Chemonics International:
$394,161,548
View countries